Journal
DISEASE MODELS & MECHANISMS
Volume 6, Issue 6, Pages 1388-1399Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.013284
Keywords
-
Categories
Funding
- Centre for Integrative Mammalian Biology
- Journal of Comparative Pathology Educational Trust
- National Institutes of Health [K01DK077956, R03DK090295]
- Crohn's and Colitis Foundation of America
- Wellcome Trust [083823/Z/07/Z, WT0087768MA]
- EU
- Biomedical Research Unit award from the National Institute for Health Research
- Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme grant for Gut Health and Food Safety [BB/J004529/1]
- SysmedIBD
- European Commission
- BBSRC [BB/J004529/1]
- Wellcome Trust [083823/Z/07/Z] Funding Source: Wellcome Trust
- BBSRC [BBS/E/F/00044446, BB/D018234/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/D018234/1, BBS/E/F/00044446] Funding Source: researchfish
- National Institute for Health Research [CL-2011-07-501] Funding Source: researchfish
Ask authors/readers for more resources
The gut barrier, composed of a single layer of intestinal epithelial cells (IECs) held together by tight junctions, prevents the entrance of harmful microorganisms, antigens and toxins from the gut lumen into the blood. Small intestinal homeostasis is normally maintained by the rate of shedding of senescent enterocytes from the villus tip exactly matching the rate of generation of new cells in the crypt. However, in various localized and systemic inflammatory conditions, intestinal homeostasis can be disturbed as a result of increased IEC shedding. Such pathological IEC shedding can cause transient gaps to develop in the epithelial barrier and result in increased intestinal permeability. Although pathological IEC shedding has been implicated in the pathogenesis of conditions such as inflammatory bowel disease, our understanding of the underlying mechanisms remains limited. We have therefore developed a murine model to study this phenomenon, because IEC shedding in this species is morphologically analogous to humans. IEC shedding was induced by systemic lipopolysaccharide (LPS) administration in wild-type C57BL/6 mice, and in mice deficient in TNF-receptor 1 (Tnfr1(-/-)), Tnfr2 (Tnfr2(-/-)), nuclear factor kappa B1 (Nf kappa b1(-/-)) or Nf kappa b2 (Nf kappa b2(-/-)). Apoptosis and cell shedding was quantified using immunohistochemistry for active caspase-3, and gut-to-circulation permeability was assessed by measuring plasma fluorescence following fluorescein-isothiocyanate-dextran gavage. LPS, at doses >= 0.125 mg/kg body weight, induced rapid villus IEC apoptosis, with peak cell shedding occurring at 1.5 hours after treatment. This coincided with significant villus shortening, fluid exudation into the gut lumen and diarrhea. A significant increase in gut-to-circulation permeability was observed at 5 hours. TNFR1 was essential for LPS-induced IEC apoptosis and shedding, and the fate of the IECs was also dependent on NF kappa B, with signaling via NF kappa B1 favoring cell survival and via NF kappa B2 favoring apoptosis. This model will enable investigation of the importance and regulation of pathological IEC apoptosis and cell shedding in various diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available